Sun Pharma Advanced Research Compa

Sun Pharma Advanced Research Company, a Mumbai‑based clinical‑stage biopharma, develops oncology and immune‑modulating drugs. Phase‑2 candidates include BCR‑ABL inhibitor Vodobatinib and S1PR1 agonist Vibozilimod, positioning it for high‑growth markets.

Headquarters: India (IND)

Sun Pharma Advanced Research Compa Logo
Company Profile
  • Employees: 316
  • HQ: Mumbai
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
SPARC Sun Pharma Advanced Research Compa
Cap: 40.3B
EQUITY NSI INR INE232I01014 Active
📈
Home Login